Vaxxinova recently announced a label change to the Vaxxon SRP Salmonella cattle vaccine. SRP Salmonella was the first USDA licensed vaccine using the widely recognized SRP technology, launched in 2005. Veterinarians and producers will see the new label circulating in the next few months.
“We listened to our customer. The product itself is not changing. The refreshed look and color scheme will be unique for each of our SRP vaccines. This change will help producers and their employees correctly identify the products,” said Jeff Williams, sales director of Vaxxon.
Managing director of Vaxxinova US, Jim Sandstrom, DVM, said that Vaxxinova will not have any lapse in product availability due to the label change. “Our team has worked efficiently to ensure the transition to the updated label is a seamless one without fulfillment delays.”
Vaxxinova International BV is a global animal health player specialized in disease and performance management of production animals. The company operates in more than 50 countries and has its headquarters in Nijmegen, The Netherlands. Vaxxinova has R&D, production and diagnostic facilities in Brazil, Chile, Germany, Italy, Japan, Jordan, the Netherlands, Norway and USA. Vaxxinova is 100% owned by the EW Group, with headquarters in Visbek, Germany.
